Compare ABCL & TRIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ABCL | TRIP |
|---|---|---|
| Founded | 2012 | 2000 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Programming Data Processing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.3B |
| IPO Year | 2020 | 2011 |
| Metric | ABCL | TRIP |
|---|---|---|
| Price | $4.21 | $10.92 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 13 |
| Target Price | $8.40 | ★ $14.40 |
| AVG Volume (30 Days) | ★ 4.0M | 3.4M |
| Earning Date | 05-11-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 10.91 | ★ 675.00 |
| EPS | N/A | ★ 0.31 |
| Revenue | $75,128,000.00 | ★ $1,556,000,000.00 |
| Revenue This Year | N/A | $3.33 |
| Revenue Next Year | $21.85 | $5.12 |
| P/E Ratio | ★ N/A | $36.11 |
| Revenue Growth | ★ 160.56 | N/A |
| 52 Week Low | $1.94 | $9.01 |
| 52 Week High | $6.52 | $20.16 |
| Indicator | ABCL | TRIP |
|---|---|---|
| Relative Strength Index (RSI) | 70.31 | 50.08 |
| Support Level | $3.91 | $9.36 |
| Resistance Level | $4.76 | $11.08 |
| Average True Range (ATR) | 0.21 | 0.46 |
| MACD | 0.05 | -0.03 |
| Stochastic Oscillator | 83.66 | 22.31 |
AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.
Tripadvisor is the world's leading travel metasearch company. Its platform offers 1 billion reviews and information on several million accommodations, restaurants, experiences, airlines, and cruises. In 2025, 42% of revenue came from the company's core Hotel and Other segment, which includes hotel revenue generated through advertising on its metasearch platform. Viator, its experiences brand, was 46% of revenue in 2025, and TheFork, its dining brand, represented 12% of sales.